Gts Securities LLC Viking Therapeutics, Inc. Put Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$47.39 - $80.2 $217,994 - $368,920
4,600 Added 10.22%
49,600 $2.63 Million
Q1 2024

May 15, 2024
BUY
$17.4 - $94.5 $506,339 - $2.75 Million
29,100 Added 183.02%
45,000 $3.69 Million
Q4 2023

Feb 14, 2024
SELL
$9.24 - $19.64 $13,860 - $29,460
-1,500 Reduced 8.62%
15,900 $295,000
Q3 2023

Nov 15, 2023
BUY
$10.92 - $16.0 $190,008 - $278,400
17,400 New
17,400 $192,000

Others Institutions Holding VKTX

# of Institutions
465
Shares Held
65.4M
Call Options Held
6.24M
Put Options Held
2.97M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.71B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email